Who are Pillar Biosciences's investors?

Pillar Biosciences's investors include Catalio Capital Management, LP, HB Ventures, Bain Capital Life Sciences, Soleus Capital.

How much funding has Pillar Biosciences raised?

Pillar Biosciences has disclosed $38M raised across 2 rounds.

Where is Pillar Biosciences headquartered?

Pillar Biosciences is headquartered in Natick, US.

Pillar Biosciences

Natick, US · Delaware corporation · 4 known investors

Find your way into Pillar Biosciences

Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Shawn LiuNamed on SEC filing

Hui YangNamed on SEC filing

Gang SongNamed on SEC filing

Zhaohui WangNamed on SEC filing

Robert ForresterDirector2020–2024Executive Officer, Director at Verastem

Hong Fang SongNamed on SEC filing

Eric LaiNamed on SEC filing

Board

Hong Fang SangBoard director

Investors · 4

Catalio Capital Management, LPlisted by Catalio Capital Management, LPNew York

How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us

HB Ventureslisted by HB VenturesVienna · $1M – $10M

How we know: HB Ventures's portfolio page · Not right? Tell us

Bain Capital Life SciencesreportedBoston

How we know: a partner's Signal profile · Not right? Tell us

Soleus CapitalreportedGreenwich

How we know: funding news · press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$38M disclosed across 2 rounds · 2020–2021

▶$20MraisedJun 2021 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Shawn LiuDirector
Hui YangDirector
Gang SongExecutive Officer, Director
Zhaohui WangDirector
Robert ForresterDirector
Hong Fang SongDirector
Eric LaiDirector

Offering amount: $50.6M
Amount sold: $20M
First sale: May 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$18MraisedMar 2020 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Hong Fang SangDirector
Shawn LiuDirector
Hui YangDirector
Gang SongExecutive Officer, Director
Zhaohui WangDirector

Offering amount: $32.4M
Amount sold: $18M
First sale: Feb 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

IQVIA58 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Precision BioSciences56 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

Fortis Life Sciences46 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

Companies competing with Pillar Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Pillar Biosciences do?: Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Who are Pillar Biosciences's investors?: Pillar Biosciences's investors include Catalio Capital Management, LP, HB Ventures, Bain Capital Life Sciences, Soleus Capital.
How much funding has Pillar Biosciences raised?: Pillar Biosciences has disclosed $38M raised across 2 rounds.
Where is Pillar Biosciences headquartered?: Pillar Biosciences is headquartered in Natick, US.